Perrigo Reports Fourth Quarter & Fiscal Year 2022 Financial Results From Continuing Operations

/PRNewswire/ -- Highlights: Perrigo fiscal year net sales grew 7.6% versus the prior year to $4.5 billion. Constant currency net sales(1) increased 12.8% and...

Related Keywords

Germany ,United States ,United Kingdom ,Belgium ,Abtei ,Rheinland Pfalz ,Ireland ,Russia ,Dublin ,Ukraine ,Irish ,American ,Murrays Kessler , ,Digestive Health ,Women Health ,Care International ,While The Company ,Company Form ,Exchange Commission ,Care International Segment ,Care Company ,Chain Reinvention Program ,Perrigo Company ,European Union ,Nestle ,Company Supply Chain Reinvention Program ,Us Internal Revenue Service ,Consumer Self Care Americas ,Consumer Self Care International ,Investor Day ,Consumer Self Care Products ,Perrigo Consumer Self Care Company ,Consolidated Statements ,Balance Sheets ,Sales Change Compared ,Consumer Self Care ,Upper Respiratory ,Latin American ,Segment Results ,Supply Chain Reinvention ,Polyethylene Glycol ,Omeprazole Cool Mint ,Supply Chain Reinvention Program ,Healthy Lifestyle ,Skin Care ,Visit Perrigo ,Proposed Assessment ,Revenue Service ,United States Securities ,Accepted Accounting Principles ,Balance Sheet ,Inflows From ,Cash Flow ,Months Ended December ,Base Erosion ,Anti Abuse Tax ,Irish Notice ,Currency Consolidated Continuing Operations ,Consolidated Continuing Operations ,Gateway Infant Formula Plant ,Perrigo Company Plc ,